drugset / Trial / NCT02006849
ACTH Treatment of APOL1- Associated Nephropathy
Withdrawn
Wake Forest University Health Sciences
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to determine if the study drug H.C. Acthar gel slows the progression of your kidney disease. This drug is a steroid-based medicine with fewer side effects than other steroids used for treatment of kidney diseases similar to APOL1 nephropathy.
Timeline
- Start
- 2014-01
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 40 unknown | Subcutaneous |
| Subject | Acthar | Peptide | 80 unknown | Subcutaneous |